Min P Kim1,2, Edward Y Chan1,2, Leonora M Meisenbach1, Razvan Dumitru3, Jessica K Brown3, Faisal N Masud3. 1. Division of Thoracic Surgery, Department of Surgery, Houston Methodist Hospital, Houston, TX, USA. 2. Department of Surgery, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX, USA. 3. Department of Anesthesiology, Houston Methodist Hospital, Houston, TX, USA.
Abstract
BACKGROUND: There is large prescription drug epidemic in United States. We want to determine if ERATS (enhanced recovery after thoracic surgery) program can reduce discharge on highly dependent narcotics. METHODS: We performed a retrospective analysis of prospectively collected data on patients who underwent lung resection and foregut procedures on thoracic surgery service over an 8-month time period. Patients underwent preoperative conditioning instructions, multimodal non-narcotic pharmaceutical usage, total intravenous anesthesia (TIVA) and minimizing highly addictive narcotics during the post-operative period. We gathered information on demographics, indication and type of surgery, morbidity, mortality and length of stay. We also recorded the type of pain medication patients were given as a prescription based on the Drug Enforcement Agency's classification schedule. RESULTS: Fifty-two patients underwent lung resection and 54 patients underwent foregut surgery. There were no mortalities in either group. Ten percent of patients after lung surgery and 6% after foregut surgery had a greater than grade II complication. The median length of stay after lung resection was 2 days and foregut surgery was 1 day. Only 10% of patients went home after lung resection and 2% after foregut surgery with a prescription for schedule II narcotics. We found that patients who were on schedule II narcotics prior to surgery all went home with schedule II narcotics. CONCLUSIONS: We found that ERATS program for thoracic surgical cases can reduce the number of patients going home with highly dependent narcotics. This strategy will decrease the availability of highly addictive prescription drugs in the community.
BACKGROUND: There is large prescription drug epidemic in United States. We want to determine if ERATS (enhanced recovery after thoracic surgery) program can reduce discharge on highly dependent narcotics. METHODS: We performed a retrospective analysis of prospectively collected data on patients who underwent lung resection and foregut procedures on thoracic surgery service over an 8-month time period. Patients underwent preoperative conditioning instructions, multimodal non-narcotic pharmaceutical usage, total intravenous anesthesia (TIVA) and minimizing highly addictive narcotics during the post-operative period. We gathered information on demographics, indication and type of surgery, morbidity, mortality and length of stay. We also recorded the type of pain medication patients were given as a prescription based on the Drug Enforcement Agency's classification schedule. RESULTS: Fifty-two patients underwent lung resection and 54 patients underwent foregut surgery. There were no mortalities in either group. Ten percent of patients after lung surgery and 6% after foregut surgery had a greater than grade II complication. The median length of stay after lung resection was 2 days and foregut surgery was 1 day. Only 10% of patients went home after lung resection and 2% after foregut surgery with a prescription for schedule II narcotics. We found that patients who were on schedule II narcotics prior to surgery all went home with schedule II narcotics. CONCLUSIONS: We found that ERATS program for thoracic surgical cases can reduce the number of patients going home with highly dependent narcotics. This strategy will decrease the availability of highly addictive prescription drugs in the community.
Entities:
Keywords:
Enhanced recovery; lung resection; narcotics; thoracic surgery
Authors: Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu Journal: JAMA Surg Date: 2017-06-21 Impact factor: 14.766
Authors: Jennifer F Waljee; David C Cron; Rena M Steiger; Lin Zhong; Michael J Englesbe; Chad M Brummett Journal: Ann Surg Date: 2017-04 Impact factor: 12.969
Authors: Kamal G Khalil; Mina L Boutrous; Adel D Irani; Charles C Miller; Timothy R Pawelek; Anthony L Estrera; Hazim J Safi Journal: Ann Thorac Surg Date: 2015-10-24 Impact factor: 4.330
Authors: Karishma Kodia; Joy A Stephens-McDonnough; Ahmed Alnajar; Nestor R Villamizar; Dao M Nguyen Journal: J Thorac Dis Date: 2021-07 Impact factor: 2.895
Authors: Haydee Del Calvo; Duc T Nguyen; Leonora M Meisenbach; Ray Chihara; Edward Y Chan; Edward A Graviss; Min P Kim Journal: J Thorac Dis Date: 2020-05 Impact factor: 2.895
Authors: Karishma Kodia; Ahmed Alnajar; Joanne Szewczyk; Joy Stephens-McDonnough; Nestor R Villamizar; Dao M Nguyen Journal: JTCVS Open Date: 2022-01-25
Authors: Terrance Peng; Kimberly A Shemanski; Li Ding; Elizabeth A David; Anthony W Kim; Michael Kim; Dustin K Lieu; Sean C Wightman; Jasmine Zhao; Scott M Atay Journal: World J Surg Date: 2021-08-04 Impact factor: 3.352